SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-295741
Filing Date
2014-08-05
Accepted
2014-08-05 16:02:56
Documents
12
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d732504d10q.htm 10-Q 319109
2 EX-10.28 d732504dex1028.htm EX-10.28 505636
3 EX-31.1 d732504dex311.htm EX-31.1 8366
4 EX-31.2 d732504dex312.htm EX-31.2 8361
5 EX-32.1 d732504dex321.htm EX-32.1 2854
6 EX-32.2 d732504dex322.htm EX-32.2 2849
  Complete submission text file 0001193125-14-295741.txt   3834917

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT mgnx-20140630.xml EX-101.INS 431125
8 XBRL TAXONOMY EXTENSION SCHEMA mgnx-20140630.xsd EX-101.SCH 38232
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mgnx-20140630_cal.xml EX-101.CAL 47585
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mgnx-20140630_def.xml EX-101.DEF 118254
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE mgnx-20140630_lab.xml EX-101.LAB 277513
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mgnx-20140630_pre.xml EX-101.PRE 215491
Mailing Address 9640 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9640 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36112 | Film No.: 141016158
SIC: 2834 Pharmaceutical Preparations